Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Measurement of, and psychological intervention with, partial adherence to inhaled antibiotic therapies in adults with cystic fibrosis
ISRCTN ISRCTN86935165
ClinicalTrials.gov identifier
Public title Measurement of, and psychological intervention with, partial adherence to inhaled antibiotic therapies in adults with cystic fibrosis
Scientific title
Acronym N/A
Serial number at source N0436130480
Study hypothesis 1. To determine factors that affect adherence to nebuliser treatment in cystic fibrosis patients
2. To evaluate a psychological intervention designed to improve adherence in those whose adherence is less than 80%
Lay summary Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Nutritional, Metabolic, Endocrine: Cystic fibrosis
Participants - inclusion criteria 1. Male and female patients with a diagnosis of cystic fibrosis
2. 18+ years of age
3. Taking nebulised colistin through the ProDose Adaptive Aerosol Delivery (AAD) system for cystic fibrosis
4. Able to use a nebuliser mouthpiece
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/03/2003
Anticipated end date 01/11/2006
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions Database analysis; Questionnaire; Randomised controlled trial ( psychological intervention versus no psychological intervention); Before-after trial.
Primary outcome measure(s) 1. The difference in adherence pre and post intervention. This will be measured using the ProDose adaptive aerosol delivery system, which records patient usage data
2. The relationship between adherence and clinical outcome such as forced expiratory volume (FEV1), use of additional antibiotic treatment and patients' own psychopathology (measured using questionnaires)
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Leeds Teaching Hospitals NHS Trust (UK)
Trial website
Publications 1. 2009 results in http://www.ncbi.nlm.nih.gov/pubmed/18952395
Contact name Miss  J E  Quinn
  Address Academic Unit Psychiatry & Behavioural Sciences
15 Hyde Terrace
University of Leeds
  City/town Leeds
  Zip/Postcode LS2 9LN
  Country United Kingdom
Sponsor Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
  Address The Department of Health,
Richmond House,
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2004
Last edited 11/07/2011
Date ISRCTN assigned 30/09/2004
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central